We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App

Smart Watches Could Identify Parkinson’s Disease Years before Symptoms Appear

By HospiMedica International staff writers
Posted on 10 Jul 2023
Print article
Image: Smart watches using AI could accurately predict those who can go on to develop Parkinson’s (Photo courtesy of Freepik)
Image: Smart watches using AI could accurately predict those who can go on to develop Parkinson’s (Photo courtesy of Freepik)

Parkinson's disease impacts brain cells known as dopaminergic neurons, predominantly located in an area called the substantia nigra. This condition leads to motor symptoms such as tremors, stiffness or rigidity, and slowed movements. Unfortunately, by the time these classic symptoms of Parkinson's become apparent, facilitating clinical diagnosis, over half of the substantia nigra cells have already died. Consequently, there's an urgent need for cost-effective, reliable, and readily available methods to detect early changes, thereby permitting intervention before the disease inflicts extensive brain damage. Now, new research has revealed that smartwatches could potentially identify Parkinson's up to seven years prior to the onset of characteristic symptoms and clinical diagnosis.

A study led by scientists at Cardiff University (Wales, UK) analyzed data gathered by smartwatches over a week, focusing on the speed of participants' movements. The researchers examined data derived from 103,712 UK Biobank participants who wore medical-grade smartwatches for a week between 2013 and 2016. These devices continuously measured average acceleration, or movement speed, throughout the seven-day span. The team compared data from a subset of participants already diagnosed with Parkinson's disease to another group diagnosed up to seven years after the smartwatch data collection. They also compared these groups to age and sex-matched healthy individuals.

The researchers discovered that they could accurately predict, using artificial intelligence (AI), who would eventually develop Parkinson's disease. Not only could they differentiate these participants from the healthy controls, but they also demonstrated that the AI could identify individuals in the general population who would later develop Parkinson's. This method was found to be more precise than any other risk factor or recognized early disease sign in predicting Parkinson's development. The machine learning model was also capable of predicting the time to diagnosis. According to the researchers, this could serve as a novel screening tool for Parkinson's disease, facilitating detection at much earlier stages than current methods permit.

“Smartwatch data is easily accessible and low-cost. As of 2020, around 30 percent of the UK population wear smart watches. By using this type of data, we would potentially be able to identify individuals in the very early stages of Parkinson’s disease within the general population,” said study leader Dr. Cynthia Sandor, Emerging Leader at the UK Dementia Research Institute at Cardiff University.

“We have shown here that a single week of data captured can predict events up to seven years in the future. With these results we could develop a valuable screening tool to aid in the early detection of Parkinson’s. This has implications both for research, in improving recruitment into clinical trials, and in clinical practice, in allowing patients to access treatments at an earlier stage, in future when such treatments become available,” added Dr. Sandor

Related Links:
Cardiff University 

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article


Surgical Techniques

view channel
Image: LUMISIGHT and Lumicell DVS offer 84% diagnostic accuracy in detecting residual cancer (Photo courtesy of Lumicell)

Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery

Breast cancer is becoming increasingly common, with statistics indicating that 1 in 8 women will develop the disease in their lifetime. Lumpectomy remains the predominant surgical intervention for treating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.